Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A TELA Bio, Inc. Filed by: LYTTON LAURENCE W

May 15, 2026 1:05 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based on 44,740,371 shares of Common Stock outstanding as of March 16, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.


SCHEDULE 13G



Lytton, Laurence W.
Signature:/s/ Laurence W. Lytton
Name/Title:Reporting Person
Date:05/15/2026

Categories

SEC Filings